Albab completed her Masters in Drug Toxicology and Safety Pharmacology from the University of Bradford. Her master’s thesis explores the Role of transport protein ATOX1 in Cisplatin Resistant Pleural Mesothelioma. Prior to joining Delphic HSE, she worked at Reckitt Benckiser as a Safety Co-ordinator where her main responsibilities were completing tox profiles and conducting risk assessments for medical devices and OTC products. She also assisted the team in MDR related projects.
Albab joined Delphic HSE in July 2024 as a Toxicologist with the EMEA team. Her main responsibilities in Delphic include the completion of toxicological profiles for cosmetic ingredients and risk assessment of finished products.
Albab Khan
Toxicologist
